Latest AI and machine learning research in other cancers for healthcare professionals.
Colorectal cancer accounts for 10% of global cancer cases in each year, making accurate evaluation a...
Despite the extensive use of biomarkers like PSA, AMACR, and PCA3, prostate cancer (PCa) is still a ...
IntroductionMesothelioma is a type of lung cancer caused by asbestos exposure, and early diagnosis i...
ObjectiveThe prediction of early response in locally advanced nasopharyngeal carcinoma (LA-NPC) afte...
Timely intervention for Alzheimer's disease (AD) requires early detection. The development of immuno...
Precise modulation of the cell cycle via electromagnetic (EM) control presents a groundbreaking appr...
Difficulty of nanomedicines to effectively penetrate the tumor core and achieve effective killing of...
BACKGROUND: CT images and circulating tumor cells (CTCs) are indispensable for diagnosing the medias...
Organoid models are powerful tools for evaluating cancer immunotherapy that provide a more accurate ...
OBJECTIVES: To develop and validate a machine learning (ML) model to differentiate malignant from be...
OBJECTIVE: PET image analysis provides tumor heterogeneity data related to neoadjuvant chemotherapy ...
BACKGROUND: The early prediction of lymph node positivity (LN+) after neoadjuvant chemotherapy (NAC)...
In breast cancer management, predicting axillary lymph node (ALN) metastasis using whole-slide image...
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive malignancy with complex molecul...
OBJECTIVES: The combination of fecal immunochemical test (FIT) followed by colonoscopy has establish...
Scoring sleep stages is essential for evaluating the status of sleep continuity and comprehending it...
Multi-modal Magnetic Resonance Imaging (MRI) provide sufficient complementary information for brain ...
Recent studies have identified microvascular invasion (MVI) as the most vital independent biomarker ...
In the context of contemporary artificial intelligence, increasing deep learning (DL) based segmenta...
IntroductionUp to 60% of adults with metastatic colorectal cancer (mCRC) receiving combination cytot...
BACKGROUND: Artificial intelligence (AI)-based imaging analysis and circulating tumor-associated DNA...